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Abstract
The Rbfox family of RNA binding proteins regulates alternative splicing of many important 
neuronal transcripts but their role in neuronal physiology is not clear1. We show here that central 
nervous system (CNS)-specific deletion of the Rbfox1 gene results in heightened susceptibility to 
spontaneous and kainic acid-induced seizures. Electrophysiological recording reveals a 
corresponding increase in neuronal excitability in the dentate gyrus of the knockout mice. Whole 
transcriptome analyses identify multiple splicing changes in the Rbfox1−/− brain with few changes 
in overall transcript abundance. These splicing changes alter proteins that mediate synaptic 
transmission and membrane excitation, some of which are implicated in human epilepsy. Thus, 
Rbfox1 directs a genetic program required in the prevention of neuronal hyperexcitation and 
seizures. The Rbfox1 knockout mice provide a new model to study the post-transcriptional 
regulation of synaptic function.
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Alternative pre-mRNA splicing is an important mechanism for regulating gene expression in 
the CNS, where it both affects neuronal development and controls functions in the mature 
brain2,3. Developmental and tissue-specific alternative splicing is mediated by cis-acting 
elements in the pre-mRNA and by corresponding trans-acting protein factors that bind these 
elements to influence adjacent spliceosome assembly. The RNA-binding Fox (Rbfox) family 
of splicing factors is comprised of three members, Rbfox1 (Fox-1 or A2BP1), Rbfox2 
(Fox-2 or RBM9), and Rbfox3 (Fox-3, HRNBP3 or NeuN). Rbfox proteins regulate splicing 
of many neuronal transcripts by binding the sequence (U)GCAUG in introns flanking 
alternative exons4–7. A (U)GCAUG motif that lies downstream of the alternative exon 
generally promotes Rbfox-dependent exon inclusion, whereas an upstream motif will 
usually repress exon inclusion4,6,8–12. Human RBFOX1 (A2BP1) was first identified 
through its interaction with Ataxin-2, the protein mutated in spinocerebellar ataxia type II13. 
Critical neurological functions for Rbfox1 are indicated by human mutations in the RBFOX1 
gene that lead to severe disorders including mental retardation, epilepsy and autism 
spectrum disorder14–17.
The three mouse Rbfox paralogues show a high degree of sequence conservation, especially 
within the RNA binding domain, which is identical between Rbfox1 and Rbfox2 and is only 
slightly altered in Rbfox3 (94% amino acid identity). Rbfox1 is specifically expressed in 
neurons, heart and muscle6,18, while Rbfox2 is expressed in these tissues plus in other cell 
types, including the embryo, hematopoetic cells and embryonic stem cells (ESCs)6,19,20. 
Expression of Rbfox3 is limited to neurons21,22. In the mature brain, most neurons express 
all three Rbfox paralogues, but certain neuronal subtypes and sporadic individual cells can 
be seen that express only one or two of the proteins23 (Fig. 1a). All three proteins have 
similar N- and C-terminal domains that are diversified by alternative promoter use and 
alternative splicing to produce a cohort of related protein isoforms with variable localization 
and splicing activities5,24,25. The three proteins apparently share some target exons, 
including exon N30 of non-muscle myosin heavy chain II-B (NMHC-B), exon N1 of c-src 
and exons 9* and 33 of the L-type calcium channel Cav1.25,6,26. There are likely other exons 
that respond to only one Rbfox protein due to differences in their expression patterns or 
protein-protein interactions.
We recently showed that the Rbfox1 transcript itself is alternatively spliced in response to 
chronic depolarization of cells, resulting in the increased expression of the nuclear, splicing-
active Rbfox1 isoform24. The change in nuclear concentration of Rbfox1 then alters the 
splicing of exons in multiple transcripts affecting neuronal excitation and calcium 
homeostasis, including the N-methyl D-aspartate (NMDA) receptor 1 (Grin1) and a calcium 
ATPase (Atp2b1). Thus, chronic stimulation controls the subcellular localization of Rbfox1, 
leading to an adaptive splicing response24. Together, these findings point to a unique role for 
Rbfox1 in regulating neuronal gene expression. However, the effect of these Rbfox1-
dependent changes on neuronal physiology in the brain is not clear. To examine the effects 
of Rbfox-dependent splicing within functioning neuronal circuits, we generated mice with 
CNS-specific deletionof Rbfox1.
Mice carrying conditional Rbfox1 alleles (Rbfox1loxP/loxP; Supplementary Fig. 1) were 
created using standard methods and crossed with mice carrying the Cre recombinase gene 
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driven by the rat Nestin promoter and enhancer (Nestin-Cre+/−), which express Cre in all 
CNS stem/neural progenitor cells27,28. The resulting heterozygous Rbfox1loxP/+/Nestin-
Cre+/− mice were crossed to Rbfox1loxP/loxP mice to obtain homozygous Rbfox1loxP/loxP/
Nestin-Cre+/− animals. Immunoblot analysis confirmed that Rbfox1−/− brains display loss of 
Rbfox1 protein (Fig. 1b). Interestingly, we observe a 60% increase in Rbfox2 protein 
expression in the Rbfox1−/− brain but no change in Rbfox3 expression (Fig. 1b and data not 
shown), suggesting a cross-regulation of Rbfox2 by Rbfox1 that balances overall Rbfox 
protein levels. By immunofluorescence, we confirmed that Rbfox1 expression is eliminated 
in the Rbfox1−/−dentate gyrus and verified that localization of the homologous splicing 
factors Rbfox2 and Rbfox3 are unchanged in these cells (Fig. 1c and data not shown). 
Rbfox1loxP/loxP/Nestin-Cre+/− mice are viable, but are slightly smaller and have reduced 
fertility compared to Rbfox1+/− or wild-type littermates (data not shown). Histological 
analysis by Nissl staining at various postnatal stages revealed that Rbfox1−/− brain gross 
morphology is normal, with no obvious anomalies in cellular architecture (Fig. 1d).
In observing the mutant mice, we found that they are prone to infrequent, spontaneous 
seizures under standard housing conditions. These seizures are accompanied by induction of 
the immediate early gene c-fos, an indirect marker for neuronal activity29. One hour after 
spontaneous seizure, c-Fos protein is highly expressed in the Rbfox1−/− amygdala and 
hippocampus (Fig. 2a), the primary areas affected in Mesial Temporal Lobe Epilepsy 
(MTLE)30. To determine if these mice also show increased susceptibility to induced 
seizures, we challenged them with systemic administration of kainic acid (KA), a well-
described method for modeling MTLE31. The behavioral response of wild-type mice, 
homozygous Rbfox1loxP/loxP/Nestin-Cre+/− mice, and heterozygous Rbfox1loxP/+/Nestin-
Cre+/− mice was continuously evaluated by the Racine Scale32 over a two hour period after 
KA administration (20 mg/kg, i.p.; Fig. 2b and data not shown). During this period, eight out 
of ten wild-type mice displayed relatively short tonic-clonic seizures (12.4±2.8 s). None of 
these mice reached stage six, defined as status epilepticus, and all survived the treatment 
(Fig. 2b and Supplementary Table 1). In contrast, Rbfox1loxP/loxP/Nestin-Cre+/− mice 
showed a dramatic response to KA, with four out of four mice reaching status epilepticus 
culminating in death in under 40 minutes. The mean tonic-clonic seizure duration was also 
significantly higher in these mice than in wild-type littermates (73.2±16.8 s; P=0.032). 
Interestingly, heterozygous Rbfox1loxP/+/Nestin-Cre+/− mice showed a KA sensitivity almost 
identical to that of homozygous mice, with four out of four dying in under 40 minutes 
(Supplementary Table 1). A heterozygous deletion of RBFOX1 was found in a human 
subject with epilepsy14; thus, increased susceptibility to seizure is caused by deletion of just 
one of the two copies of Rbfox1 in mice and apparently humans. Notably, Rbfox2loxP/loxP/
Nestin-Cre+/− mice do not show susceptibility to spontaneous or KA-induced seizures (Fig. 
2b and Supplementary Table 1), indicating that Rbfox1 and Rbfox2 are not fully redundant 
in their neuronal functions. The different phenotypes of the Rbfox1 and Rbfox2 knockout 
mice likely result, at least in part, from differences in their target exon sets. However, the 
infrequent neurons expressing only one protein or the other could also contribute to the 
observed phenotypic differences.
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To explore the physiological basis of these seizure data, we investigated changes in neuronal 
excitability by analyzing the synaptic input/output (I/O) relationship in wild-type and 
Rbfox1−/− dentate gyrus. Field excitatory postsynaptic potentials (fEPSPs) were measured in 
the molecular layer in response to stimulation of the lateral perforant path using varying 
stimulus widths. We found that the stimulus intensities required to evoke fEPSPs in the 
Rbfox1−/− brain were lower than those required for wild-type brain, as shown by 
representative fEPSP raw traces (Fig. 2c) and average I/O curves (Fig. 2d). The grand 
average I/O relationships for individual experiments were fit with a Boltzmann function, 
where W50 is the stimulus width that elicits the half-maximal response and k is the slope 
factor. Consistent with an increase in network excitability, Rbfox1−/− slices exhibit a shift to 
the left in the I/O relationship and a decrease in the W50 value to 41% that of wild-type 
slices (Fig. 2d). Thus, the loss of Rbfox1 causes an increase in excitability of the neuronal 
population of the dentate gyrus.
To determine if the increase in excitability results from an increase in synapse number, we 
quantified spine density along granule cell dendrites of the dentate gyrus using the Golgi 
Cox staining method. We found a very modest decrease in spine density along Rbfox1−/− 
dendrites compared to wild-type dendrites (Supplementary Fig. 2a c). Similarly, the 
Rbfox1−/− hippocampus showed no changes in expression of the synaptic marker proteins 
Synapsin-I and PSD-95 (Supplementary Fig. 2d,e). Thus, altered synaptic function, rather 
than synapse number, is likely responsible for the increased neuronal excitability of the 
Rbfox1−/− brain.
To survey the changes in exon inclusion in the Rbfox1−/− brain compared to wild-type, we 
used Affymetrix exon-junction (MJAY) microarrays to assay transcript abundance and 
alternative splicing across the genome (Supplementary Table 2; full dataset is available 
online at Gene Expression Omnibus (GEO), at http://www.ncbi.nlm.nih.gov/geo/query/
acc.cgi?acc=GSE28421). The MJAY arrays offer broad coverage but do not have probes for 
all exons, so to extend the analysis, we also directly assayed by RT-PCR candidate exons 
that are known to be regulated by Rbfox1 or to be present in genes implicated in epilepsy. 
Combining the RT-PCR validated array exons and directly tested candidate exons, we 
identified a total of 20 statistically significant splicing changes in the Rbfox1−/− brain 
compared to wild-type (Table 1 and Supplementary Fig. 3). This list is not comprehensive, 
but compared to mice lacking other splicing factors such as Nova33 or nPTB (unpublished 
data), Rbfox1 knockout mice show relatively few splicing changes in the brain. This may 
result from compensation for the loss of Rbfox1 by Rbfox2, which is upregulated in the 
Rbfox1−/− brain (Fig. 1b). The heterozygous Rbfox1+/− brain exhibits many of the splicing 
changes observed in the Rbfox1−/− brain, but these changes are generally smaller in 
magnitude and show large variation between biological replicates (data not shown). Many 
exons altered in Rbfox1−/− brain also change in the Rbfox2−/− brain, as expected from the 
overlap in their targets. However, some exons, including exons of the NMDA receptor 1 
(Grin1), the voltage-gated potassium channel Kv4.3 (Kcnd3), and the L-type calcium 
channel Cav1.3α1 (Cacna1d), are more responsive to loss of Rbfox1 than Rbfox2 (Fig. 3a). 
Since Rbfox2loxP/loxP/Nestin-Cre+/− mice are not prone to seizures, transcripts more strongly 
controlled by Rbfox1 may have a crucial effect on the hyperexcitation phenotype.
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Nearly all of the identified exons possess (U)GCAUG motifs in their flanking introns, and 
are likely to be directly regulated by Rbfox1. In total, 85% of exons (11 out of 13) showing 
reduced inclusion in the Rbfox1−/− brain contain a (U)GCAUG within the proximal 300 
nucleotides downstream of the exon - consistent with a loss of Rbfox1 activation; 86% of 
exons (6 out of 7) showing increased inclusion possess a Rbfox binding site within 300 
nucleotides upstream - consistent with a loss of Rbfox1 repression (Table 1). This represents 
a substantial enrichment of Rbfox binding motifs in the knockout-responsive exons. Of the 
5166 alternative cassette exons probed by the MJAY array, only 1590 (31%) possess a 
(U)GCAUG motif within 300 nucleotides downstream and only 1328 (26%) possess this 
motif within 300 nucleotides upstream. Characterization of Rbfox1 binding sites in mouse 
cortex using individual-nucleotide resolution crosslinking immunoprecipitation (iCLIP)12,34 
confirms that a majority of these exons exhibit adjacent Rbfox1 binding in vivo, and are thus 
direct targets of the protein (Figure 3b and data not shown). However, these analyses require 
more data before a genomewide map of Rbfox1 binding can be developed.
Notably, there were minimal changes in the overall expression of genes across the array. 
Besides the expected loss of Rbfox1 mRNA, only two significant changes in transcript 
abundance were detected in the Rbfox1−/− brain (Pop4 and AK138161, encoding a 
hypothetical protein expressed in mouse hypothalamus). The effect of Rbfox1 is primarily 
post-transcriptional. We also examined the protein expression of several well-characterized 
splicing factors in the Rbfox1−/− brain. Most of the proteins tested, including Ptbp1 (PTB) 
and Mbnl1, were unchanged in the Rbfox1−/− brain. The neuron-specific splicing factor 
Nova1 was moderately decreased (Supplementary Fig. 4). Rbfox1 apparently affects the 
post-transcriptional regulation of Nova1, with loss of Rbfox1 resulting in reduced Nova1 
expression. This is interesting in light of previous findings of a significant overlap between 
the Nova1 and Rbfox1 protein regulatory networks35. It is also notable that Rbfox1 targets 
are enriched in synaptic functions, similar to Nova1. The potential cross-regulation of these 
factors will likely be another connection between their regulatory programs.
The splicing changes in the Rbfox1−/− brain affect multiple functional components of 
synaptic transmission that could clearly contribute to the epileptic phenotype (Table 1). 
Transcripts for ion channels such as the voltage-gated potassium channel Kv4.3 (Kcnd3) and 
the L-type calcium channel subunits Cav1.1α (Cacna1s) and Cav1.3α1 (Cacna1d) were 
significantly altered in the Rbfox1−/− brain. Transcripts encoding neurotransmitter receptors 
such as the gamma-aminobutyric acid (GABA)-A receptor subunit γ2 (Gabrg2) and the 
NMDA receptor 1 (Grin1) were also changed in the Rbfox1−/−brain. We also found splicing 
changes in transcripts for structural proteins of the synapse, such as neurexin 3 (Nrxn3) and 
for vesicle fusion proteins including syntaxin 3 (Stx3), synaptosomal-associated protein 25 
(Snap25), and the calcium-dependent secretion activator (Cadps). Changes in intracellular 
calcium dynamics are associated with epileptogenesis, including alterations in calcium entry 
through voltage-gated channels or changes in calcium buffering by calcium-binding 
proteins36. In addition to the splicing changes in the voltage-gated channels mentioned 
above, we identified changes in transcripts for calcium/calmodulin-dependent protein kinase 
II (Camk2g), calmodulin binding transcription activator (Camta1), and calmodulin-
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dependent calcineurin subunit (Ppp3ca). Disruption of calcium dynamics may contribute to 
the epileptic phenotype observed in Rbfox1loxP/loxP/Nestin-Cre+/−mice.
Most interestingly, a number of the Rbfox1 target transcripts have been directly linked to 
epilepsy (Table 2). Mutations in the Gabrg2 gene have been identified in human epilepsy 
patients37, and changes in expression of NMDA receptor 1 (Grin1) or the voltage-gated 
sodium channel Nav1.6 (Scn8a) alter seizure susceptibility in mice38–40. Transgenic mouse 
models have revealed that changes in expression or alternative splicing of Snap25 result in 
seizures41,42. In particular, it was found that the splicing ratio of a pair of Snap25 mutually 
exclusive exons is developmentally regulated and that removal of the exon 5b 
predominantly expressed in adult brain results in spontaneous seizures42. We find that the 
splicing of this same adult-specific exon is reduced by 24% in the Rbfox1−/− brain and 
reduced by a much lesser extent (12%) in the Rbfox2−/− brain (Table 1 and Fig. 3b). We also 
identified a number of Rbfox1 iCLIP reads surrounding (U)GCAUG motifs adjacent to exon 
5b (Fig. 3b), indicating that Rbfox1 directly regulates the splicing of this exon. The change 
in Rbfox1-dependent Snap25 splicing likely contributes to the seizure phenotype of Rbfox1 
knockout mice.
In summary, our findings demonstrate a critical role of Rbfox1 in neuronal function. We 
previously showed that changes in Rbfox1 activity in response to chronic stimuli can 
homeostatically adjust the level of splicing for its target exons. The limited response of 
Rbfox2 and Rbfox3 to depolarizing media (unpublished observations) and the abnormal 
physiology of the Rbfox1 knockout brain indicate that these proteins are not fully redundant 
in their functions, and that Rbfox1 plays a unique role in the cellular response to 
overexcitation. The Rbfox1 knockout mice provide a new model for examining how 
modifications of synaptic proteins determine excitation and epileptogenesis. Splicing 
regulation by Rbfox1 is clearly affecting neuronal excitation. However, the presence of 
cytoplasmic Rbfox1 protein and its binding to 3′ UTRs indicates that there will be other 
components to the Rbfox1−/− phenotype. Examination of the larger nuclear and cytoplasmic 
programs of post-transcriptional regulation by Rbfox1 should yield new insights into the 
control of cellular homeostasis and its misregulation in neurological disease.
MATERIALS AND METHODS
Mice
We used homologous recombination to create “floxed” Rbfox1 alleles consisting of loxP 
sites flanking Rbfox1 exons 11 and 12, annotated as previously described25. Southern blot 
hybridization probes were generated by PCR amplification (Supplementary Table 3), cloned 
using the TOPO TA cloning kit (Invitrogen), and labeled by PCR in the presence of α-32P-
dCTP. Mouse strain 129S6/SVEvTac BAC library (RPCI-22), arrayed on high density nylon 
filters, was obtained from Children’s Hospital Oakland Research Institute (CHORI) and 
probe Rbfox1_knpr_frt was used to screen the BAC library. Positive clones were purchased 
from CHORI and validated by BAC end sequencing. Clone RP22-344J23 was used to 
construct the “floxed” Rbfox1 targeting cassette also carrying a neomycin resistance (neo) 
cassette flanked by Frt sites43 and the primer sequences used for recombineering are listed 
in Supplementary Table 3. The targeting cassette was transfected into 129S2/Sv embryonic 
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stem cells at the University of California, San Diego (UCSD) Transgenic and Gene 
Targeting Core. Clones that had undergone homologous recombination were identified by 
Southern blot using the 5′ and 3′ probes after digesting the genomic DNA with SwaI and 
SpeI (Supplementary Fig. 1). Cells from positive clones were injected into a C57BL/6J 
blastocyst at the UCSD transgenic and gene targeting core, and one line was found to have 
germline transmission. Heterozygous (Rbfox1loxP/+) F1 offspring were crossed to transgenic 
mice expressing Flp recombinase44 to excise the neo cassette. Resulting Heterozygous 
(Rbfox1loxP/+) mice lacking the neo cassette were intercrossed to produce homozygous 
(Rbfox1loxP/loxP) mice. Homozygous mice were then crossed to transgenic Nestin-Cre+/− 
mice, allowing for restricted deletion of Rbfox1 in the CNS of double transgenic mice 
(Rbfox1loxP/loxP/Nestin-Cre+/−). Primers used for genotyping the Rbfox1+, Rbfox1loxP and 
Rbfox1Δ alleles are listed in Supplementary Table 3 and product sizes are given in 
Supplementary Fig. 1. Mice used for this study were maintained on a mixed 129S2/Sv × 
C57BL/6J background. Animals were housed in a 12-h light/dark cycle with food and water 
available ad libitum and were maintained by the University of California, Los Angeles 
(UCLA) Association for Assessment and Accreditation of Laboratory Animal Care 
accredited Division of Laboratory Medicine. All experiments were Institutional Animal Care 
and Use Committee approved by the UCLA Chancellor’s Animal Research Council.
Western blotting
Nuclei were isolated from wild-type, Rbfox1+/− and Rbfox1−/− brains as previously 
described45. Nuclei were lysed in Lysis Buffer (20 mM Hepes-KOH, pH 7.9, 300 mM NaCl, 
1 mM EDTA, 0.75% NP-40) containing complete protease inhibitors (PI; Roche) for 10 min 
on ice. For quantification of synaptic proteins or splicing factors, hippocampi or total brains, 
respectively, were dissected from wild-type and Rbfox1loxP/loxP/Nestin-Cre+/− mice and 
homogenized by sonication in RIPA buffer containing PI. Nuclear and total protein samples 
were cleared, boiled in SDS loading buffer, and resolved on 10% Tris-glycine gels. 
Antibodies were used at the following dilutions: α-Rbfox1 1D1024, 1:2000; α-Rbfox2, 
1:2000 (Bethyl); α-U1-70K, 1:5000; α-Synapsin-I, 1:2000 (Millipore); α-PSD-95, 1:2000 
(Millipore); α-GAPDH, 1:10,000 (Ambion); α-PTB NT4856, 1:2500; α-nPTB IS2, 1:3000; 
α-Mbnl1, 1:1000 (Millipore); α-Nova-1, 1:1000 (Millipore); α-hnRNPA1, 1:1000; α-
SRp20, 1:1500 (Zymed); α-β-tubulin, 1:100 (Santa Cruz); and ECL Plex Cy3-conjugated 
goat α-mouse and Cy5-conjugated goat α-rabbit secondary antibodies, 1:2500 (GE 
Healthcare).
Histology and immunohistochemistry
Rbfox1loxP/loxP/Nestin-Cre+/− and wild-type littermates were transcardially perfused with 
ice-cold 0.1 M phosphate buffered saline (PBS; pH 7.4), followed by ice-cold 4% 
paraformaldehyde in PBS (pH 7.4). Brains were cryoprotected in 30% sucrose and 40 μm 
free-floating sections were cut in the coronal orientation using a Microm HM505E cryostat. 
For Nissl histology, sections were hydrated and stained using 0.25% thionin acetate (Sigma), 
dehydrated through alcohols, cleared in xylenes, and mounted with DPX (Electron 
Microscopy Sciences). For double immunofluorescent staining, sections were blocked 30 
min with blocking solution (10% normal goat serum, 0.1% Triton X-100 in PBS) and 
incubated with primary antibodies at 4°C overnight. Sections were washed three times and 
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stained with secondary antibodies in PBS for 2 h. Sections were again washed three times, 
mounted with ProLong Gold plus DAPI reagent (Invitrogen) and imaged using a Zeiss LSM 
510 Meta confocal microscope. The following primary antibodies were used: α-Rbfox1 
1D10, 1:200; α-Rbfox2, 1:200 (Bethyl); α-c-Fos Ab-5, 1:1600 (Calbiochem). Alexa Fluor 
488-conjugated goat α-mouse IgG and Alexa Fluor 568-conjugated goat α-rabbit IgG 
secondary antibodies (Molecular Probes) were used at 1:1000. For Golgi-Cox staining, wild-
type and Rbfox1−/− brains were processed using the FD Rapid GolgiStain Kit (FD 
Neurotechnologies) according to the manufacturer’s instructions and counterstained with 
thionin acetate. For spine quantification, the analyzer was blind to the experimental group 
throughout the analysis. Dendrites of the same size in diameter from dentate gyrus granule 
cells were randomly selected from 4 slices per individual animal. A total of 28–29 dendritic 
segments from 2 animals per genotype were used for quantification. Images were collected 
under a 100× oil-immersion objective using the Spot RT KE camera and software system 
(Diagnostic Instruments). Spines were operationally defined as any protrusion less than 5 
μm in length. Each spine was manually traced and dendritic length was measured using 
ImageJ software. The spine numbers were expressed as mean spine density per 10 μm of 
linear dendritic length. For all histology and immunofluorescence experiments, images 
shown are representative of at least 2 independent samples.
Behavioral observation of KA-induced seizures
KA (Sigma) was dissolved in sterile saline and administered i.p. at 20 mg/kg body weight. 
Ten wild-type mice, 4 heterozygous Rbfox1loxP/+/Nestin-Cre+/− mice, 4 homozygous 
Rbfox1loxP/loxP/Nestin-Cre+/−mice, and 4 homozygous Rbfox2loxP/loxP/Nestin-Cre+/− mice 
(2–3 mo of age) were used. In all experiments, the experimenter was blind to the genotype 
of the animals and each experiment used at least one wild-type littermate. Seizure severity 
was determined according to the Racine Scale32: stage 0: normal behavior; stage 1: mouth 
and facial movements; stage 2: head bobbing; stage 3: forelimb clonus; stage 4: rearing; 
stage 5: continuous rearing and falling (tonic-clonic seizures); stage 6: status epilepticus 
and/or death. For each animal, the seizure score was determined every 10 min for 2 h after 
KA administration. Each animal’s maximum score for each 10 min interval was used to 
calculate the mean seizure score (± s.e.m.) for each experimental group. Latency to first 
stage 5 (tonic-clonic) seizure, duration of each stage 5 seizure and time to death were 
measured from time of KA administration. Statistical significance was determined using 
one-tailed Student’s t test. The level of significance was set to P<0.05.
Electrophysiology
To obtain synaptic input/output curves, hippocampal field potential recordings were carried 
out as previously described46. Coronal hippocampal slices (350 μm thick) were prepared 
from 3 adult (2–3 mo old) wild-type and 3 Rbfox1loxP/loxP/Nestin-Cre+/− mice. Hippocampal 
field recordings were performed at 32–34°C under standard conditions in an interface 
chamber perfused with normal artificial cerebral spinal fluid (nACSF) solution containing 
(in mM): 126 NaCl, 2.5 KCl, 2 CaCl2, 1–2 MgCl2, 1.25 NaHPO4, 26 NaHCO3, and 10 D-
glucose, pH 7.3–7.4 (bubbled with 95% O2 and 5% CO2. Field potentials were evoked by 
lateral perforant path stimulation at 0.05 Hz, and responses were recorded in the dentate 
gyrus molecular layer. Bipolar electrodes were used to deliver a constant-current stimulus. 
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The stimulus intensity was determined by recording a threshold response at a width (W) of 
60 μs with no response at 20 μs. The W of the stimulus was increased stepwise by 20 μs to 
create I/O curves ranging from 20 to 240 μs. Four population field EPSPs (fEPSPs) were 
recorded at each W, and the maximum slope of the responses (volts per second) was 
measured over a 0.5–1 ms window of the fEPSP rising phase. The average slope was 
calculated at each W used. Input/output curves were fit with a Boltzmann equation: f(W) = 
(MAX/(1 + exp((W - W50)/k)) + MAX), where W is stimulus width, MAX is the maximum 
response, k is a slope factor, and W50 is the stimulus width that elicits 50% of MAX. The 
fitted parameters were compared between experimental groups, and statistical significance 
was determined using a one-way ANOVA, followed by Bonferroni’s corrected t-tests.
Splicing microarrays
Total RNA was extracted by Trizol® reagent (Invitrogen) from whole brain of 3 wild-type 3 
and Rbfox1loxP/loxP/Nestin-Cre+/− mice, all 1-mo-old males. Ribosomal RNAs were 
removed from samples using the RiboMinus Transcriptome Isolation Kit (Invitrogen) 
according to the manufacturer’s instructions. Amplified, biotinylated cDNA target was 
produced using the GeneChip® Whole Transcript Sense Target Labeling and Control 
Reagents kit (Affymetrix) according to the manufacturer’s instructions. Each sample target 
was hybridized overnight to a Mouse GeneSplice Array (Affymetrix PN 540092). 
Hybridized arrays were processed using the Affymetrix Fluidics Station 450 and scanned 
with an Affymetrix GeneChip scanner. Data were analyzed and each alternative event was 
assigned an MJAY ratio, a measure of the difference in the average ratio of inclusion to 
skipping for the indicated exon in the Rbfox1−/− samples compared to wild-type, as 
previously described47. The top 25 significant changes, ranked in descending order by the 
absolute value of the MJAY ratio, of alternative cassettes and mutually exclusive exons are 
shown in Supplementary Table 2.
RT-PCR assay
Total RNA was extracted by TrizolR reagent (Invitrogen) from whole brain of 1-mo-old 
wild-type, Rbfox1loxP/loxP/Nestin-Cre+/−, and Rbfox2loxP/loxP/Nestin-Cre+/− mice (n = 3 for 
each genotype). One μg of total RNA was reverse-transcribed with random hexamers. One-
tenth of this reaction was then amplified in 24 cycles of PCR with exon-specific primers, 
one of which was 32P-labeled. The PCR products were resolved on 8% polyacrylamide/7.5 
M urea denaturing gels. The gel was dried, exposed, and scanned in a Typhoon 9400 
PhosphorImager scanner (GE Healthcare). Images were analyzed with ImageQuant TL 
Software. Mean exon inclusion levels were calculated for wild-type and Rbfox1−/−brains, 
and the percent change in inclusion (ΔPSI) was calculated by subtracting the Rbfox1−/− 
mean inclusion level from the wild-type mean inclusion level. Statistical significance was 
determined using the paired, one-tailed Student’s t test with significance set to P<0.05. RT-
PCR primers are listed in Supplementary Table 3.
Rbfox1-RNA crosslinking immunoprecipitation analysis (Rbfox1 iCLIP)
The Rbfox1 iCLIP was done as previously described34 with the following modifications: 
cortices from 1.5-mo-old male and female wild-type C57BL/6J mice were dissected, 
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triturated in 8 ml ice cold HBSS with 20 mM HEPES-KOH pH 7.5, and UV irradiated in a 
Stratalinker 1800 (Stratagene) at 750 mJ/cm2. Rbfox1 was immunoprecipitated with 1D10 
antibody and washed with high salt buffer. The immobilized crosslinked RNA was 
fragmented as previously described12: aliquots of beads in 50 μl of 1× micrococcal nuclease 
buffer with 5.0 μg yeast tRNA were treated with 5 or 2,000 Kunz U/ml of micrococcal 
nuclease (New England Biolabs) for 5 min at 37°C. The enzyme was inhibited by addition 
of 0.5 ml 1× PNK buffer + EGTA. The RNA fragments were dephosphorylated for 1 h to 
remove the 3′-phosphorylates left by micrococcal nuclease. The RNA linker contained 3′ 
biotin instead of the puromycin group used previously34. Since Rbfox1 co-migrates with the 
IgG heavy chain, the crosslinked protein-RNA-linker products were purified on monomeric 
avidin beads (Fischer Scientific) before resolving on 10% NuPAGE gel (Invitrogen). The 
constructed Rbfox1 iCLIP library was sequenced on a Genome Analyzer IIx (Illumina) with 
a 76 nt read length. Mapping of sequence reads was performed against the mouse genome 
(version mm9/NCBI37) using Bowtie version 0.12.548 as previously described34.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Rbfox1−/− brains lack Rbfox1 protein expression but possess normal morphology
(a) Confocal immunofluorescence microscopy on coronal sections of wild-type (WT) 
dentate gryus probed for Rbfox1 (green) and Rbfox2 (red); overlayed images are shown in 
the far right panels. Arrows point to cells expressing only Rbfox1; arrowheads point to cells 
expressing only Rbfox2. Scale bar, 100 μm. (b) Immunoblot analysis of Rbfox1 and Rbfox2 
in nuclear lysates isolated from WT, Rbfox1+/− and Rbfox1−/− brains. U1-70K was used as a 
loading control for total nuclear protein. Below each gel is the amount of Rbfox1 or Rbfox2 
protein in each sample as a percentage of WT, normalized by U1-70K expression. (c) 
Confocal immunofluorescence microscopy on coronal sections of WT and Rbfox1−/− 
dentate gyrus probed for Rbfox1 (green) and Rbfox2 (red) expression. Overlayed images are 
shown in the far right panels. Scale bar, 100 μm. (d) Representative Nissl stain of WT and 
Rbfox1−/−hippocampus at 1 mo of age showing normal gross morphology. Scale bar, 0.5 
mm. Abbreviations: CA1/CA3, pyramidal layers of the hippocampus; DG, dentate gyrus.
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Figure 2. Rbfox1−/− brains are epileptic and hyperexcitable
(a) c-Fos immunostaining on WT and Rbfox1−/− coronal brain sections 1 h after a 
spontaneous seizure in the Rbfox1loxP/loxP/Nestin-Cre+/−mouse. Relevant brain areas are 
indicated. Abbreviations: amyg, amygdala; CA1/CA3, pyramidal cell layers of the 
hippocampus; DG, dentate gyrus; ent, entorhinal cortex; II-III indicate layers of the cerebral 
cortex. Scale bar, 2 mm. (b) Progression of behavioral changes after systemic KA 
administration (20mg/kg, i.p.) in WT, Rbfox1loxP/loxP/Nestin-Cre+/−, and Rbfox2loxP/loxP/
Nestin-Cre+/−mice over a 2 h observation period. Seizures were scored on the Racine Scale 
as described31 and data shown are mean scores. Error bars, s.e.m. (c) Representative fEPSP 
traces from individual electrophysiological recordings in WT and Rbfox1−/− dentate gyrus. 
(d) Average synaptic I/O curves in WT and Rbfox1−/− dentate fit with a Boltzmann function 
(solid lines). Circles are grand-averaged scores; error bars, s.e.m. W50, stimulus width that 
elicits 50% of the maximum response; k, slope factor. n = 3 mice, 16–20 slices per 
experimental group.
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Figure 3. Rbfox1−/− brain exhibits splicing changes in transcripts affecting synaptic function and 
neuronal excitation
(a) Denaturing gel electrophoresis of RT-PCR products for three Rbfox1-dependent exons. 
Above each gel is a schematic depicting the alternative exon (horizontal black box) and the 
relative location of (U)GCAUG binding sites (yellow boxes) in the flanking introns (thin 
horizontal lines). Shown below each gel is a graph quantifying the mean percentage of 
alternative exon inclusion (% Ex In, PSI) in WT (black bars), Rbfox1 knockout (KO; red 
bars), and Rbfox2 KO (blue bars) brain. (b) A schematic showing the Snap25 mutually 
exclusive exon pair, 5a (horizontal black box) and 5b (horizontal gray box), plus the 
intervening intron and the promixal 500 nt of the adjacent introns. Yellow boxes represent 
(U)GCAUG motifs. The distribution of Rbfox1 iCLIP reads (horizontal green bars) is shown 
above. A histogram displaying the conservation of this region among 30 vertebrate species, 
as determined by phastCons (http://genome.ucsc.edu), is shown below. A score of 1 
indicates 100% identity among all species at that nt position. Chromosomal location in nt is 
shown above the iCLIP data. At the bottom, the RT-PCR assay and quantification of exons 
5a and 5b splicing is shown, with the inclusion of the downstream exon plotted. For (a) and 
(c), error bars represent s.e.m.; n = 3. *P<0.05 and n.s. = not significant by paired, one-tailed 
Student’s t test. Exact P values are shown in Table 1.
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